New 'Microbial' vaccine seeks to train immune system to fight lymphoma
Disease control
Recruiting now
This study is testing a new type of treatment called EO2463, which is a therapeutic vaccine designed to teach the body's immune system to recognize and attack lymphoma cells. It will be given to patients with slow-growing non-Hodgkin's lymphoma, both by itself and in combination …
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC